Skip to main content

Table 1 Baseline characteristics of the included cancer patients who died due to infectious disease

From: Infectious diseases as a cause of death among cancer patients: a trend analysis and population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results database

 

Overall

Other infectious and parasitic diseases, including HIV

Pneumonia and influenza

Septicemia

Syphilis

Tuberculosis

P value

n

151,440

47,310

72,133

31,119

35

843

 

Age, mean (SD) in years

66.33 (17.18)

51.51 (17.11)

74.43 (11.82)

70.00 (12.77)

67.77 (17.33)

69.17 (12.92)

 < 0.001

Sex (%)

Female

57,511 (38.0)

10,912 (23.1)

31,595 (43.8)

14,689 (47.2)

15 (42.9)

300 (35.6)

 < 0.001

Male

93,929 (62.0)

36,398 (76.9)

40,538 (56.2)

16,430 (52.8)

20 (57.1)

543 (64.4)

 

Survival, mean (SD) in months

65.31 (78.17)

38.12 (61.18)

81.09 (81.72)

70.14 (81.85)

74.10 (87.83)

57.43 (69.14)

 < 0.001

Grade (%)

B-cell; pre-B; B-precursor

7818 (5.2)

4899 (10.4)

1898 (2.6)

1001 (3.2)

1 (2.9)

19 (2.3)

 < 0.001

Moderately differentiated; Grade II

33,347 (22.0)

5243 (11.1)

19,510 (27.0)

8384 (26.9)

11 (31.4)

199 (23.6)

 

NK cell; natural killer cell (1995+)

20 (0.0)

11 (0.0)

4 (0.0)

4 (0.0)

0 (0.0)

1 (0.1)

 

Null cell; non-T-non-B

36 (0.0)

22 (0.0)

10 (0.0)

4 (0.0)

0 (0.0)

0 (0.0)

 

Poorly differentiated; Grade III

20,022 (13.2)

3458 (7.3)

11,114 (15.4)

5330 (17.1)

3 (8.6)

117 (13.9)

 

T-cell

709 (0.5)

428 (0.9)

182 (0.3)

96 (0.3)

0 (0.0)

3 (0.4)

 

Undifferentiated; anaplastic; Grade IV

4096 (2.7)

1135 (2.4)

2002 (2.8)

933 (3.0)

2 (5.7)

24 (2.8)

 

Unknown

72,008 (47.5)

30,021 (63.5)

29,289 (40.6)

12,279 (39.5)

15 (42.9)

404 (47.9)

 

Well differentiated; Grade I

13,384 (8.8)

2093 (4.4)

8124 (11.3)

3088 (9.9)

3 (8.6)

76 (9.0)

 

Laterality (%)

Bilateral, single primary

1198 (0.8)

739 (1.6)

290 (0.4)

160 (0.5)

2 (5.7)

7 (0.8)

 < 0.001

Left—origin of primary

20,467 (13.5)

5006 (10.6)

10,792 (15.0)

4542 (14.6)

4 (11.4)

123 (14.6)

 

Not a paired site

104,929 (69.3)

35,125 (74.2)

48,181 (66.8)

21,046 (67.6)

23 (65.7)

554 (65.7)

 

Only one side—side unspecified

331 (0.2)

114 (0.2)

139 (0.2)

74 (0.2)

0 (0.0)

4 (0.5)

 

Paired site, but no information concerning laterality

2177 (1.4)

949 (2.0)

879 (1.2)

326 (1.0)

0 (0.0)

23 (2.7)

 

Paired site: midline tumour

31 (0.0)

8 (0.0)

15 (0.0)

8 (0.0)

0 (0.0)

0 (0.0)

 

Right—origin of primary

22,307 (14.7)

5369 (11.3)

11,837 (16.4)

4963 (15.9)

6 (17.1)

132 (15.7)

 

Race (%)

American Indian/Alaska Native

738 (0.5)

292 (0.6)

285 (0.4)

148 (0.5)

1 (2.9)

12 (1.4)

 < 0.001

Asian or Pacific Islander

7494 (4.9)

2074 (4.4)

3948 (5.5)

1313 (4.2)

0 (0.0)

159 (18.9)

 

Black

19,020 (12.6)

8249 (17.4)

5647 (7.8)

4951 (15.9)

10 (28.6)

163 (19.3)

 

Unknown

711 (0.5)

213 (0.5)

423 (0.6)

68 (0.2)

0 (0.0)

7 (0.8)

 

White

123,477 (81.5)

36,482 (77.1)

61,830 (85.7)

24,639 (79.2)

24 (68.6)

502 (59.5)

 

Behavior (%)

Benign

1067 (0.7)

234 (0.5)

497 (0.7)

331 (1.1)

2 (5.7)

3 (0.4)

 < 0.001

Borderline malignancy

2182 (1.4)

525 (1.1)

890 (1.2)

745 (2.4)

0 (0.0)

22 (2.6)

 

In situ

8110 (5.4)

2188 (4.6)

4082 (5.7)

1796 (5.8)

4 (11.4)

40 (4.7)

 

Malignant

140,081 (92.5)

44,363 (93.8)

66,664 (92.4)

28,247 (90.8)

29 (82.9)

778 (92.3)

 

Marital status (%)

Divorced

10,617 (7.0)

3768 (8.0)

4358 (6.0)

2424 (7.8)

2 (5.7)

65 (7.7)

 < 0.001

Married

64,925 (42.9)

12,993 (27.5)

35,789 (49.6)

15,691 (50.4)

17 (48.6)

435 (51.6)

 

Separated

2043 (1.3)

566 (1.2)

1036 (1.4)

413 (1.3)

1 (2.9)

27 (3.2)

 

Single

34,464 (22.8)

23,609 (49.9)

7133 (9.9)

3607 (11.6)

8 (22.9)

107 (12.7)

 

Unknown

9519 (6.3)

2709 (5.7)

4562 (6.3)

2185 (7.0)

0 (0.0)

63 (7.5)

 

Unmarried or domestic Partner

39 (0.0)

31 (0.1)

4 (0.0)

4 (0.0)

0 (0.0)

0 (0.0)

 

Widowed

29,833 (19.7)

3634 (7.7)

19,251 (26.7)

6795 (21.8)

7 (20.0)

146 (17.3)

Â